Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets

BACKGROUND: Molecular markers of clinical outcome may aid in designing targeted treatments for bladder cancer. However, only a few bladder cancer biomarkers have been examined as therapeutic targets. METHODS: Data from The Cancer Genome Atlas (TCGA) and bladder specimens were evaluated to determine...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Cancer
Auteurs principaux: Morera, Daley S, Hennig, Martin S, Talukder, Asif, Lokeshwar, Soum D, Wang, Jiaojiao, Garcia-Roig, Michael, Ortiz, Nicolas, Yates, Travis J, Lopez, Luis E, Kallifatidis, Georgios, Kramer, Mario W, Jordan, Andre R, Merseburger, Axel S, Manoharan, Murugesan, Soloway, Mark S, Terris, Martha K, Lokeshwar, Vinata B
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2017
Sujets:
Translational Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5680466/
https://ncbi.nlm.nih.gov/pubmed/28972965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.318
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires